Anti-TNF for post-operative prevention in Crohn's disease: the detection of anti-drug antibodies at time of surgery is associated with an increased risk of endoscopic recurrence

Claude Auzolle (1) , Pascal Houze (2) , My-linh Tran-Minh (1) , Stéphane Nancey (3) , Anthony Buisson (4, 5) , Mathurin Fumery (6) , Benjamin Pariente (7) , F. Djenidi (1) , Philippe Marteau (8) , Yoram Bouhnik (9) , Philippe Seksik (10) , Matthieu Allez (10)

1 AP-HP - Hopital Saint-Louis [AP-HP]
2 Service de Biochimie [AP-HP Hôpital Saint-Louis, Paris]
3 Service d'Hépatologie et de Gastroentérologie [Lyon]
4 M2iSH - Microbes, Intestin, Inflammation et Susceptibilité de l'Hôte
5 Service d'Hépatologie Gastro-entérologie [CHU Clermont-Ferrand]
6 Service d'Hépato Gastroenterologie [CHU Amiens-Picardie]
7 Hôpital Claude Huriez [Lille]
8 Service d'Hépato-gastro-entérologie [CHU Saint-Antoine]
9 Service de Gastroentérologie [Hôpital Beaujon]
10 Service de Gastroentérologie et nutrition [CHU Saint-Antoine]

Domaines: Sciences du Vivant [q-bio]; Hépatologie et Gastroentérologie

Claude Auzolle, Pascal Houze, My-linh Tran-Minh, Stéphane Nancey, Anthony Buisson, et al.. Anti-TNF for post-operative prevention in Crohn's disease: the detection of anti-drug antibodies at time of surgery is associated with an increased risk of endoscopic recurrence. 12. Congress of ECCO, European Crohn’s and Colitis Organisation, Feb 2017, Barcelone, Spain. ⟨hal-03553320⟩